Page 586 - medicina-integrativa_compress

594 PARTE II, SECCIÓN 9 OBSTETRICIA/GINECOLOGÍA

79. Bolli P, Simpson FO: Clonidine in menopausal flushing: A 106. Kritz-Silverstein D, et al: Isoflavones and cognitive function in
double-blind trial. N Z Med J 82:196-197, 1975. older women: The SOy and Postmenopausal Health In Aging
80. Lindsay R, Hart DM: Failure of response of menopausal vasomotor (SOPHIA) Study. Menopause 10:196-202, 2003.
symptoms to clonidine. Maturitas 1:21-25, 1978. 107. Faure ED, Chantre P, Mares P: Effects of a standardized soy extract
81. Salmi T, Punnonen R: Clonidine in the treatment of menopausal on hot flushes: A multicenter, double-blind, randomized, placebo-
symptoms. Int J Gynaecol Obstet 16:422-426, 1979. controlled study. Menopause 9:329-334, 2002.
82. Edington RF, Chagnon JP, Steinberg WM: Clonidine (Dixarit) for 108. Scambia G, et al: Clinical effects of a standardized soy extract
menopausal flushing. Can Med Assoc J 123:23-26, 1980. in postmenopausal women: A pilot study. Menopause 7:105-111,
83. Wren BG, Brown LB: A double-blind trial with clonidine and a 2000.
placebo to treat hot flushes. Med J Aust 144:369-370, 1986. 109. Russo R, Corosu R: The clinical use of a preparation based on
84. Nappi C, et al: The effect of various drugs with neuroendocrine phyto-oestrogens in the treatment of menopausal disorders. Acta
activity and transdermal estradiol on plasma gonadotropin Biomed Ateneo Parmense 74:137-143, 2003.
concentrations after ovariectomy in reproductive-aged women. 110. Tice JA, et al: Phytoestrogen supplements for the treatment of hot
Acta Obstet Gynecol Scand 70:435-439, 1991. flashes: The Isoflavone Clover Extract (ICE) Study: A randomized
85. Anderson O, Engebretsen T, Solberg VM, et al: alpha-Methyldopa controlled trial. JAMA 290:207-214, 2003.
for climacteric hot flushes: A double-blind, randomized, cross-over 111. Atkinson C, et al: Red-clover-derived isoflavones and
study. Acta Obstet Gynecol Scand 65:405-409, 1986. mammographic breast density: A double-blind, randomized,
86. Hammond MG, Hatley L, Talbert LM: A double blind study to placebo-controlled trial (ISRCTN42940165). Breast Cancer Res
evaluate the effect of methyldopa on menopausal vasomotor 6:R170-R179, 2004.
flushes. J Clin Endocrinol Metab 58:1158-1160, 1984. 112. Baber RJ, et al: Randomized placebo-controlled trial of an
87. Nesheim BI, Saetre T: Reduction of menopausal hot flushes by isoflavone supplement and menopausal symptoms in women.
methyldopa: A double blind crossover trial. Eur J Clin Pharmacol Climacteric 2:85-92, 1999.
20:413-416,1981. 113. Knight DC, Howes JB, Eden JA: The effect of Promensil, an isoflavone
88. Bergmans M, Merkus JM, Corbey RS, et al: Effect of Bellergal Retard extract, on menopausal symptoms. Climacteric 2:79-84, 1999.
on climacteric complaints: A double-blind placebo-controlled study. 114. Brzezinski A, Aldercreutz H, Shaol R, et al: Short term effects of
Maturitas 9:227-234, 1987. phytoestrogen rich diet on postmenopausal women. Menopause
89. Guttuso T Jr, et al: Gabapentin’s effects on hot flashes in 4:89-94, 1997.
postmenopausal women: A randomized controlled trial. Obstet 115. Carranza-Lira S, et al: Changes in symptoms, lipid and hormone
Gynecol 101:337-345, 2003. levels after the administration of a cream with phytoestrogens in
90. Albertazzi P, et al: The effect of dietary soy supplementation on hot the Climacteric—preliminary report. Int J Fertil Womens Med
flushes. Obstet Gynecol 91:6-11, 1998. 46:296-299, 2001.
91. Albertazzi P, et al: Dietary soy supplementation and phytoestrogen 116. Crisafulli A, et al: Effects of genistein on hot flushes in early
levels. Obstet Gynecol 94:229-231, 1999. postmenopausal women: A randomized, double-blind EPT- and
92. Balk JL, et al: A pilot study of the effects of phytoestrogen placebo-controlled study. Menopause 11:400-404, 2004.
supplementation on postmenopausal endometrium. J Soc 117. Komesaroff PA, et al: Effects of wild yam extract on menopausal
Gynecol Invest 9:238-242, 2002. symptoms, lipids and sex hormones in healthy menopausal women.
93. Burke GL, et al: Soy protein and isoflavone effects on vasomotor Climacteric 4:144-150, 2001.
symptoms in peri- and postmenopausal women: The Soy Estrogen 118. Nikander E, et al: A randomized placebo-controlled crossover trial
Alternative Study. Menopause 10:147-153, 2003. with phytoestrogens in treatment of menopause in breast cancer
94. Dalais FS, et al: Effects of dietary phytoestrogens in postmenopausal patients. Obstet Gynecol 101:1213-1220, 2003.
women. Climacteric 1:124-129, 1998. 119. Sammartino A, et al: Effects of genistein on the endometrium:
95. Han KK, et al: Benefits of soy isoflavone therapeutic regimen on ultrasonographic evaluation. Gynecol Endocrinol 17:45-49, 2003.
menopausal symptoms. Obstet Gynecol 99:389-394, 2002. 120. Lehmann-Willenbrock W, Riedel HH: Clinical and endocrinologic
96. Knight DC, et al: Effects on menopausal symptoms and acceptability examinations concerning therapy of climacteric symptoms
of isoflavone-containing soy powder dietary supplementation. following hysterectomy with remaining ovaries. Zent BL Gynakol
Climacteric 4:13-18, 2001. 110:611-618, 1998.
97. Murkies AL, et al: Dietary flour supplementation decreases 121. Warnecke G: Influence of a phytopharmaceutical on climacteric
post-menopausal hot flushes: Effect of soy and wheat. Maturitas complaints. Die Medizinische Welt 36:871-874, 1985.
21:189-195, 1995. 122. Stoll W: Phytopharmacon influences atrophic vaginal epithelium:
98. St Germain A, et al: Isoflavone-rich or isoflavone-poor soy protein Double-blind study, Cimicifuga vs. estrogenic substances.
does not reduce menopausal symptoms during 24 weeks of Therapeutikon 1:23-31, 1987.
treatment. Menopause 8:17-26, 2001. 123. Jacobson JS, et al: Randomized trial of black cohosh for the
99. Washburn S, et al: Effect of soy protein supplementation on serum treatment of hot flashes among women with a history of breast
lipoproteins, blood pressure, and menopausal symptoms in cancer. J Clin Oncol 19:2739-2745, 2001.
perimenopausal women. Menopause 6:7-13, 1999. 124. Wuttke W, Seidlova-Wuttke D, Gorkow C: The Cimicifuga
100. Van Patten CL, et al: Effect of soy phytoestrogens on hot flashes preparation BNO 1055 vs. conjugated estrogens in a double-blind
in postmenopausal women with breast cancer: A randomized, placebo-controlled study: Effects on menopause symptoms and
controlled clinical trial. J Clin Oncol 20:1449-1455, 2002. bone markers. Maturitas 44 (Suppl 1):S67-S77, 2003.
101. Penotti M, et al: Effect of soy-derived isoflavones on hot flushes, 125. Osmers R, Friede M, Liske E, et al: Efficacy and safety of
endometrial thickness, and the pulsatility index of the uterine isopropanolic black cohosh extract for climacteric symptoms.
and cerebral arteries. Fertil Steril 79:1112-1117, 2003. Obstet Gynecol 105:1074-1083, 2005.
102. Secreto G, et al: Soy isoflavones and melatonin for the relief of 126. Hernandez Munoz G, Pluchino S: Cimicifuga racemosa for the
climacteric symptoms: A multicenter, double-blind, randomized treatment of hot flushes in women surviving breast cancer.
study. Maturitas 4:11-20, 2004. Maturitas 22(Suppl 1):S59-S65, 2003.
103. Upmalis DH, et al: Vasomotor symptom relief by soy isoflavone 127. Barton DL, Loprinzi CL, Quella SK, et al: Prospective evaluation of
extract tablets in postmenopausal women: A multicenter, vitamin E for hot flashes in breast cancer survivors. J Clin Oncol
double-blind, randomized, placebo-controlled study. 16:495-500, 1998.
Menopause 7:236-242, 2000. 128. Blatt MH, Wiesbader H, Kupperman HS: Vitamin E and climacteric
104. Quella SK, Loprinzi CL, Barton DL, et al: Evaluation of soy syndrome: Failure of effective control as measured by menopausal
phytoestrogens for the treatment of hot flashes in breast cancer index. AMA Arch Intern Med 91:792-799, 1953.
survivors: A North Central Cancer Treatment Group trial. J Clin 129. Cagnacci A, et al: Kava-kava administration reduces anxiety in
Oncol 18:1068-1074, 2000. perimenopausal women. Maturitas 44:103-109, 2003.
105. Duffy R, Wiseman H, File SE: Improved cognitive function 130. Rachev E, et al: Efficacy and safety of phospholipid liposomes in the
in postmenopausal women after 12 weeks of consumption of a treatment of neuropsychological disorders associated with the
soya extract containing isoflavones. Pharmacol Biochem Behav menopause: A double-blind, randomised, placebo-controlled study.
75:721-729, 2003. Curr Med Res Opin 17:105-110, 2001.